This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Dana-Farber-Cancer Institute Inc., Harvard College. Active years: 2022-2025.
Company Filing History:
2 out of 1,265 
2 out of 3,071 
Years Active: 2022-2025
Title: Maria F Murphy: Innovator in Chemotherapy-Induced Neuropathy Treatment
Introduction
Maria F Murphy is a prominent inventor based in Revere, MA (US). She has made significant contributions to the field of medicine, particularly in the treatment of chemotherapy-induced peripheral neuropathy and hearing loss. With a total of 2 patents, her work is paving the way for innovative therapeutic approaches.
Latest Patents
Maria's latest patents focus on BCL-W polypeptides and mimetics for treating or preventing chemotherapy-induced peripheral neuropathy and hearing loss. The compositions and methods she developed involve administering a BCL-W protein, a BH4 domain-containing fragment, or a BCL-W mimetic to subjects in need. These groundbreaking methods aim to alleviate the side effects of chemotherapy, enhancing the quality of life for patients undergoing treatment.
Career Highlights
Throughout her career, Maria has worked with esteemed institutions such as the Dana-Farber Cancer Institute and Harvard College. Her research has garnered attention for its potential impact on patient care and treatment outcomes.
Collaborations
Maria has collaborated with notable colleagues, including Rosalind Segal and Loren D Walensky. These partnerships have further enriched her research and contributed to the advancement of her innovative work.
Conclusion
Maria F Murphy stands out as a dedicated inventor whose work addresses critical challenges in cancer treatment. Her contributions to the field are invaluable, and her patents represent a significant step forward in improving patient care.